Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.
Level 5 - mechanism / opinion, no new human data
Preclinical bench and animal study (mice and in vitro cell culture).
PubMed 18549472 · doi:10.1186/1471-2210-8-10
What was done
Researchers evaluated the bioavailability of benfotiamine in mice and cultured cells. Mice received either a single oral dose (100 mg/kg solubilized in 200 mM hydroxypropyl-beta-cyclodextrin) or daily oral dosing for 14 days, with thiamine and thiamine phosphate levels measured in blood, liver, and brain. In vitro, cultured neuroblastoma cells were incubated with 10 µM benfotiamine, and the rate of intracellular thiamine uptake was compared to genuine thiamine in thiamine-depleted cells.
What was found
In mice, a single oral dose rapidly increased thiamine levels in blood and liver to peak concentrations within 1 to 2 hours, but caused no significant increase in the brain. Repeated daily administration for 14 days significantly elevated thiamine derivatives in the liver compared to controls, but showed no significant increase in the brain. In cultured neuroblastoma cells, 10 µM benfotiamine did not increase intracellular thiamine, and in thiamine-depleted cells, intracellular thiamine rose more rapidly with genuine thiamine than with benfotiamine, which showed a lag period. Specific numerical values and variance were not reported in the abstract.
Why it matters
This study demonstrates that benfotiamine primarily enhances thiamine status in peripheral organs rather than the central nervous system. It clarifies that benfotiamine does not share the brain-penetrating properties of lipid-soluble thiamine disulfide derivatives like sulbutiamine or fursultiamine.
Limits
The abstract does not state the sample sizes (n) for animal cohorts or cell culture replicates, nor does it provide quantitative pharmacokinetic parameters. The findings are restricted to mouse and cell culture models and may not fully reflect human central nervous system pharmacokinetics.
Cited by
- supports Allithiamine is a fat-soluble form of vitamin B1 that crosses the blood-brain barrier into the inner ear.